Merriman Curhan Ford downgrades Exelixis (Nasdaq: EXEL) from Buy to Neutral. Price target range to $6-7 from $7-8.

Merriman analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE